Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
SIGA TECHNOLOGIES INC (SIGA)
|
Add to portfolio |
|
|
|
| Price: |
$7.03
| | Metrics |
| OS: |
71.1
|
M
| |
23
|
% ROE
|
| Market cap: |
$500
|
M
| |
48
|
% ROIC
|
|
Net cash:
|
$76.2
|
M
| |
$1.07
|
per share
|
|
EV:
|
$423
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$34.4
|
M
| |
12.3
|
x EV/EBITDA
|
|
EBIT
|
$33.9
|
M
| |
12.5
|
x EV/EBIT
|
| EPS |
$0.39
| |
18.2
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 110.8 | 133.7 | 125.0 | 26.7 | 477.1 | 12.3 | 15.0 | 8.2 |
| Revenue growth | -17.1% | 7.0% | 367.3% | -94.4% | 3788.3% | -18.1% | 83.3% | 160.4% |
| Cost of goods sold | 10.4 | 16.6 | 14.8 | 1.8 | 95.3 | 0.0 | 0.0 | 0.0 |
| Gross profit | 100.3 | 117.1 | 110.2 | 25.0 | 381.8 | 12.3 | 15.0 | 8.2 |
| Gross margin | 90.6% | 87.6% | 88.2% | 93.3% | 80.0% | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative | 35.1 | 18.0 | 14.7 | 13.3 | 12.9 | 12.3 | 13.7 | 10.6 |
| Research and development | 22.5 | 9.9 | 10.9 | 13.3 | 13.0 | 16.7 | 19.7 | 13.1 |
| EBIT | 42.7 | 89.1 | 84.5 | -2.3 | 355.1 | -18.8 | -31.0 | -16.5 |
| EBIT margin | 38.5% | 66.7% | 67.6% | -8.7% | 74.4% | -153.6% | -206.9% | -202.4% |
| Pre-tax income | 44.1 | 89.3 | 73.5 | -10.2 | 411.6 | -38.3 | -39.7 | -39.0 |
| Income taxes | 10.2 | 19.9 | 17.2 | -2.9 | -10.2 | -2.1 | 0.0 | 0.5 |
| Tax rate | 23.2% | 22.2% | 23.4% | 28.9% | | 5.5% | | |
| Net income | 33.9 | 69.5 | 56.3 | -7.2 | 421.8 | -36.2 | -39.7 | -39.5 |
| Net margin | 30.6% | 52.0% | 45.1% | -27.1% | 88.4% | -295.3% | -264.9% | -482.5% |
| |
| Diluted EPS | $0.46 | $0.91 | $0.71 | ($0.09) | $5.10 | ($0.46) | ($0.69) | ($0.73) |
| Shares outstanding (diluted) | 73.5 | 76.4 | 79.4 | 82.2 | 82.7 | 78.9 | 57.2 | 53.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|